HLS Therapeutics Inc. (TSX:HLS)
3.790
+0.090 (2.43%)
Aug 28, 2026, 3:59 PM EST
HLS Therapeutics Employees
HLS Therapeutics had 85 employees as of December 31, 2025. The number of employees decreased by 7 or -7.61% compared to the previous year.
Employees
85
Change (1Y)
-7
Growth (1Y)
-7.61%
Revenue / Employee
939.66K CAD
Profits / Employee
-143.18K CAD
Market Cap
117.24M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 85 | -7 | -7.61% |
| Dec 31, 2024 | 92 | 1 | 1.10% |
| Dec 31, 2023 | 91 | -8 | -8.08% |
| Dec 31, 2022 | 99 | 7 | 7.61% |
| Dec 31, 2021 | 92 | 4 | 4.55% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Ascend Wellness Holdings | 2,200 |
| Organigram Global | 1,120 |
| Planet 13 Holdings | 650 |
| Cannara Biotech | 452 |
| Charlotte's Web Holdings | 112 |
| Medexus Pharmaceuticals | 90 |
HLS Therapeutics News
- 13 days ago - HLS Therapeutics upgraded to Buy from Hold at Canaccord - TheFly
- 13 days ago - HLS Therapeutics upgraded to Strong Buy from Outperform at Raymond James - TheFly
- 18 days ago - HLS Therapeutics Q2 Earnings Call Highlights - MarketBeat
- 18 days ago - HLS Therapeutics Earnings Call Transcript: Q2 2026 - Transcripts
- 18 days ago - HLS Therapeutics Earnings release: Q2 2026 - Filings
- 18 days ago - HLS Therapeutics Registration statement: Q2 2026 - Filings
- 18 days ago - HLS Therapeutics Registration statement: Q2 2026 - Filings
- 18 days ago - HLS Therapeutics Slides: Q2 2026 - Filings